Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for ms 1
Most Correlated Studies
- Pancreatic cell lines treated with chromatin-targeting small molecules
- Plasma cell leukemia L-363 cells treated with rapamycin and MS-275 alone or in combination
- Esophageal cancer cell line response to single or combined azacytidine and MS-275 treatments
- Colorectal cancer Caco-2et cells with dox-induced KRAS G12V mutation and with MS-275
- Bone marrow stromal MS5 cells treated with MEK inhibitor (PD184352)
Most Relevant Literature
- Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma P…
- Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CV…
- Deficiency for scavenger receptors Stabilin-1 and Stabilin-2 leads to age-dependent renal and hepati…
- Stabilin-1 plays a protective role against Listeria monocytogenes infection through the regulation o…
- Identifying Stabilin-1 and Stabilin-2 Double Knockouts in Reproduction and Placentation: A Descripti…
Most Relevant Clinical Trials
- A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
- Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Rec…
- A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerabilit…
- The Energetic Origin of Neurodegeneration in MS
- Protective Stepping & MS
